Please Upload related files below
Fill in below.
Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery - link your account with SnapTrade.
On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products. The warning letter stated that the pumps were “adulterated” and “misbranded” and noted the Company’s modifications “can significantly impact the functionality of the device with respect to the infusion pumps delivery profile, alarm functionality. The FDA stated that these changes may have significantly impacted the safety and efficacy of the devices, raising concerns about the adequacy of ICU Medical’s regulatory disclosures.
Following this news, shares of ICU Medical, Inc. fell over 4% on the same day.